Picard Medical, Inc.PMIEarnings & Financial Report
NYSE · Health Care · Surgical & Medical Instruments & Apparatus
PMI Q3 FY2025 Key Financial Metrics
Revenue
$1.2M
Gross Profit
$-130.0K
Operating Profit
$-3.5M
Net Profit
$-10.4M
Gross Margin
-11.0%
Operating Margin
-293.8%
Net Margin
-878.3%
YoY Growth
N/A
EPS
$-0.19
Picard Medical, Inc. Q3 FY2025 Financial Summary
Picard Medical, Inc. reported revenue of $1.2M for Q3 FY2025, with a net profit of $-10.4M (-878.3% margin). Cost of goods sold was $1.3M, operating expenses totaled $3.4M.
Key Financial Metrics
| Total Revenue | $1.2M |
|---|---|
| Net Profit | $-10.4M |
| Gross Margin | -11.0% |
| Operating Margin | -293.8% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
Picard Medical, Inc. Q3 FY2025 revenue of $1.2M breaks down across 2 segments, led by Products at $1.1M (93.9% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $1.1M | 93.9% |
| Other | $72.0K | 6.1% |
Picard Medical, Inc. Revenue by Segment — Quarterly Trend
Picard Medical, Inc. revenue by segment across the last 2 reported quarters, showing how each business line (such as Products and Other) has evolved quarter over quarter.
| Segment | Q3 FY2025 | Q2 FY2025 |
|---|---|---|
| Products | $1.1M | $2.1M |
| Other | $72.0K | — |
Picard Medical, Inc. Quarterly Revenue & Net Profit History
Picard Medical, Inc. results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $1.2M | — | $-10.4M | -878.3% |
| Q2 FY2025 | $2.1M | — | $-6.7M | -315.5% |
Income Statement
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Revenue | $2.1M | $1.2M |
| YoY Growth | N/A | N/A |
Balance Sheet
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Assets | $11.7M | $13.5M |
| Liabilities | $45.9M | $5.6M |
| Equity | $-54.5M | $8.0M |
Cash Flow
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Operating CF | $-4.8M | $-6.5M |